Article Sidebar

PDF
Date Published: 31/10/2022
Abstract Views: 127
Views PDF: 143
DOI: https://doi.org/10.47972/vjcts.v39i.810
Issue
Vol. 39
Section
Research Article
How to Cite
Dung, V. H., Binh, P. T., Hoa, N. T., & Trang, B. M. (2022). Case report: Bilateral hypertrophic obstructive cardiomyophathy associated with myocardial bridge . The Vietnam Journal of Cardiovascular and Thoracic Surgery, 39, 122-125. https://doi.org/10.47972/vjcts.v39i.810

Case report: Bilateral hypertrophic obstructive cardiomyophathy associated with myocardial bridge

Van Hung Dung, Pham Thanh Binh, Nguyen Tien Hoa, Bui Minh Trang

Main Article Content

Abstract

Hypertrophic obstructive cardiomyopathy is a rare cardiac disease occurring in approximately 0.2% of the population and is usually left ventricular hypertrophy associated with or without mitral regurgitation due to SAM syndrome. Medical treatment, first septal ablation with absolute alcohol, or left ventricular myectomy are the treatment methods for this disease. We report the surgical results of a case of obstructive bilateral ventricular hypertrophy associated with a myocardial bridging of the left anterior descending artery.

Article Details

Keywords

bệnh cơ tim phì đại, hội chứng SAM, cầu cơ

References

1. BJ.Maron. Hypertrophic Cardiomyopathy. A Systematic Review. JAMA 2002;287:1308-1320.
2. D. Mozaffarian, and JH. Caldwell. Right Ventricular Involvement in Hypertrophic Cardiomyopathy: A Case Report and Literature Review. Clin. Cardiol 2001;24:2-8.
3. Y.Wang, X. Zhao, M. Zhai, Y.Huang, Q. Zhou, Y. Zhang, et al. Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not? BMC Cardiovascular Disorders 2022; 22:168.
4. J Seo, YJ Hong, YJ Kim, P Lkhagvasuren, I Cho, CY Shim et al. Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy. Scientific Reports 2020; 10:21908
5. MC Digilio and B Marino. Clinical manifestations of Noonan syndrome. Images Paediatr Cardiol. 2001;3(2):19-30.
6. BA. Houston and GR. Stevens. Hypertrophic Cardiomyopathy: A Review. Clinical Medicine Insights: Cardiology 2014:8(S1) 53–65. DOI: 10.4137/CMC.S15717.
7. I. Olivotto, F Girolami, S. Nistri, A.Rossi, L. Rega, F. Garbini, et al. The Many Faces of Hypertrophic Cardiomyopathy: From Developmental Biology to Clinical Practice. J. of Cardiovasc. Trans. Res. 2009; 2:349–367. DOI: 10.1007/s12265-009-9137-2.
8. MT. Corban, OY Hung, P Eshtehardi, E Rasoul-Arzrumly, M McDaniel, G Mekonnen, et al. Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies. J Am Coll Cardiol. 2014;63(22):2346-55.
9. Shi-Min Yuan. Myocardial Bridging. Braz J Cardiovasc Surg 2016;31(1):60-2
Hemmati P, Schaff HV, Dearani JA, Daly RC, Lahr BD, and Lerman A. Clinical Outcomes of Surgical Unroofing of Myocardial Bridging in Symptomatic Patients. Ann Thorac Surg 2019; doi.org/10.1016/j.athoracsur.2019.07.005.